Overview
Premier Health Q3 revenue falls to CAD 21.9 mln
Net loss for Q3 was CAD 3.5 mln, improved from CAD 8.4 mln last year
Adjusted EBITDA for Q3 was CAD 22K, down from CAD 367K in 2024
Outlook
Premier Health adapts cost structure in British Columbia
Company committed to cost reduction and debt management
Result Drivers
VOLUME DECLINE - Adjusted EBITDA impacted by reduced volumes in Quebec and British Columbia
BILL 10 IMPACT - Quebec's Bill 10 continued to affect Per Diem segment, now 4% of revenues
WILDFIRE EVACUATIONS - Contract cancellations in Ontario due to wildfires affected revenue
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue |
| C$21.90 mln |
|
Q3 Net Income |
| -C$3.50 mln |
|
Q3 Adjusted EBITDA |
| C$22,000 |
|
Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Premier Health of America Inc is C$0.20, about 77.5% above its August 20 closing price of C$0.05
Press Release: ID:nGNX2WZw9t